+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

North America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 120 Pages
  • North America
From
Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Middle East, Africa
From
Latin America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Primary Myelofibrosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Primary Myelofibrosis Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Secondary Myelofibrosis Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Secondary Myelofibrosis Therapeutics Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Thrombin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Thrombin Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Antiplatelet Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiplatelet Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cold Agglutinin Disease Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cold Agglutinin Disease Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
VONVENDI Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

VONVENDI Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 140 Pages
  • Global
From
Gliclazide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Gliclazide Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 82 Pages
  • Global
From
Ferrous Fumarate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Ferrous Fumarate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 97 Pages
  • Global
From
Industrial Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Industrial Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • October 2023
  • 129 Pages
  • Global
From
Integrin Beta 3 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Integrin Beta 3 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 85 Pages
  • Global
From
Hemophilia a (Factor Viii Deficiency) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hemophilia a (Factor Viii Deficiency) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 406 Pages
  • Global
From
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 150 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 394 Pages
  • Global
From
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 77 Pages
  • Global
From
Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 53 Pages
  • Global
From
Hemophilia A and B - Epidemiology Forecast to 2030 - Product Thumbnail Image

Hemophilia A and B - Epidemiology Forecast to 2030

  • Report
  • October 2021
  • 54 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more